Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
351.20
-3.80 (-1.07%)
At close: Oct 23, 2025
SHA:688506 Revenue
Sichuan Biokin Pharmaceutical had revenue of 103.76M CNY in the quarter ending June 30, 2025, with 14.52% growth. This brings the company's revenue in the last twelve months to 441.19M, down -92.40% year-over-year. In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B with 936.31% growth.
Revenue (ttm)
441.19M
Revenue Growth
-92.40%
P/S Ratio
328.66
Revenue / Employee
156.23K
Employees
2,521
Market Cap
145.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Huadong Medicine | 42.62B |
WuXi AppTec | 41.90B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |
Shanghai Fosun Pharmaceutical (Group) | 40.12B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Jiangsu Hengrui Medicine | 30.15B |
Zhejiang NHU Company | 22.87B |
Aier Eye Hospital Group | 21.94B |